Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients

Clinical trial NCT05361057 · TERMINATED

Trial details

NCT number: NCT05361057
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Measurable Disease

Start date: 2022-06-29
Primary completion: 2023-02-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.